全文获取类型
收费全文 | 35952篇 |
免费 | 2386篇 |
国内免费 | 130篇 |
专业分类
耳鼻咽喉 | 443篇 |
儿科学 | 817篇 |
妇产科学 | 470篇 |
基础医学 | 4769篇 |
口腔科学 | 597篇 |
临床医学 | 3864篇 |
内科学 | 7196篇 |
皮肤病学 | 564篇 |
神经病学 | 3029篇 |
特种医学 | 1501篇 |
外科学 | 6152篇 |
综合类 | 319篇 |
一般理论 | 41篇 |
预防医学 | 2716篇 |
眼科学 | 794篇 |
药学 | 2396篇 |
中国医学 | 24篇 |
肿瘤学 | 2776篇 |
出版年
2024年 | 39篇 |
2023年 | 222篇 |
2022年 | 378篇 |
2021年 | 928篇 |
2020年 | 541篇 |
2019年 | 853篇 |
2018年 | 973篇 |
2017年 | 756篇 |
2016年 | 805篇 |
2015年 | 891篇 |
2014年 | 1382篇 |
2013年 | 1645篇 |
2012年 | 2852篇 |
2011年 | 2840篇 |
2010年 | 1581篇 |
2009年 | 1297篇 |
2008年 | 2409篇 |
2007年 | 2548篇 |
2006年 | 2428篇 |
2005年 | 2436篇 |
2004年 | 2230篇 |
2003年 | 2073篇 |
2002年 | 1984篇 |
2001年 | 317篇 |
2000年 | 225篇 |
1999年 | 309篇 |
1998年 | 409篇 |
1997年 | 299篇 |
1996年 | 241篇 |
1995年 | 304篇 |
1994年 | 193篇 |
1993年 | 177篇 |
1992年 | 159篇 |
1991年 | 142篇 |
1990年 | 113篇 |
1989年 | 115篇 |
1988年 | 111篇 |
1987年 | 89篇 |
1986年 | 102篇 |
1985年 | 93篇 |
1984年 | 113篇 |
1983年 | 99篇 |
1982年 | 102篇 |
1981年 | 87篇 |
1980年 | 86篇 |
1979年 | 56篇 |
1978年 | 45篇 |
1977年 | 57篇 |
1976年 | 43篇 |
1974年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
101.
Specificity of blebbistatin, an inhibitor of myosin II 总被引:10,自引:0,他引:10
Limouze J Straight AF Mitchison T Sellers JR 《Journal of muscle research and cell motility》2004,25(4-5):337-341
Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined
the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of
the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin
IIA and IIB with IC50 values ranging from 0.5 to 5 μM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is
only poorly inhibited (IC50=80 μM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
102.
103.
Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. 总被引:9,自引:0,他引:9
Bernard Meshi Timothy Z Vitalis Diana Ionescu W Mark Elliott Chun Liu Xiang-Dong Wang Shizu Hayashi James C Hogg 《American journal of respiratory cell and molecular biology》2002,26(1):52-57
This study was designed to test the hypothesis that cigarette smoke-induced inflammation and emphysema are amplified by the presence of latent adenoviral (Ad) infection, and to determine whether this emphysematous process can be reversed by all-trans-retinoic acid (RA) treatment. The results confirm that in guinea pigs, chronic cigarette-smoke exposure caused lesions similar to human centrilobular emphysema. They also show that latent Ad infection combined with cigarette-smoke exposure caused an excess increase in lung volume (P < 0.001), air-space volume (P < 0.001), and lung weight (P < 0.01), and further decrease in surface-to-volume ratio (P < 0.001) compared with smoke exposure alone. RA treatment failed to reverse these emphysematous changes. Analysis of inflammatory response in parenchymal and airway tissue showed that smoking caused an increase of polymorphonuclear leukocytes (PMNs) (P < 0.0002), macrophages (P < 0.001), and CD4 cells (P < 0.0009), and that latent Ad infection independently increased PMNs (P < 0.001), macrophages (P = 0.003), and CD8 cells (P < 0.001). We conclude that latent Ad infection amplifies the emphysematous lung destruction and increases the inflammatory response produced by cigarette-smoke exposure. In this study, the increase in CD4 was associated with cigarette smoke and the increase in CD8 cells with latent Ad infection. 相似文献
104.
Slovenia initiated a nation-wide project to introduce smart cards in the health sector in 1995 and its full-scale deployment started in September 2000. Although the basic aim of the project was to support insurance related procedures, the system was designed in a flexible and open manner to present an infrastructure for the whole health sector. The functionality of the current system is described in this paper along with lessons learned so far. The upgrade of the system is outlined, with emphasis on technical details, the objective being to provide a real-time EDI based environment for a general set of applications in the medical sector, supported by the flexibility and security of modern smart card technologies. Integration with similar systems in other EU countries is discussed. 相似文献
105.
Seven independently isolated revertants of temperature-sensitive mutants in the 72K protein of Ad5 were tested for the ability to transform rat cells under a variety of conditions. Using the continuous cell line designated CREF, at 36° the range of transformation phenotypes of the different revertants included a frequency characteristic of WT and also the elevated frequency associated with the parental temperature-sensitive alleles. Transformation frequency did not correlate with other phenotypes, such as plaque size or plaquing efficiency on HeLa cells at 38.5°–39°. Therefore, although it is likely that the 72K protein modulates transformation, it is possible to dissociate genetically this regulatory function of the protein from its replicative function in permissive infection. 相似文献
106.
Turner CK Blieden TM Smith TJ Feldon SE Foster DC Sime PJ Phipps RP 《Journal of immunological methods》2004,291(1-2):63-70
The purpose of this study was to develop an enzyme-linked immunospot assay (ELISpot assay) that can be used with human adherent cells. While standard enzyme-linked immunosorbent assays (ELISAs) are available and widely used and ELISpot assays are used for nonadherent lymphocytes, no ELISpot assay has been developed for adherent cells. We used primary human fibroblasts from four different tissues (myometrium, lung, gingiva, and orbit), either unstimulated or interleukin (IL)-1beta-activated, to evaluate an ELISpot assay. Antibody pairs for IL-6 and IL-8 were used and results were compared to a standard ELISA. We found that we could reliably detect IL-6 and IL-8 spots with as few as 10 fibroblasts. Optimal cell numbers were 50 cells per well incubated for 8 h, although spots appeared as early as 2 h after incubation. Spots were absent when cells, primary, or secondary anti-cytokine antibodies were omitted from the protocol. Spot number and size can be ascertained using current automated ELISpot reader technology. The frequency of IL-6 and IL-8-producing human fibroblasts could also be determined. For example, 60% of the lung fibroblasts express IL-6, but IL-8 can be detected from only 40% of the cells. Approximately 80% of the human orbital fibroblasts make IL-6, whereas approximately 50% generate IL-8 following IL-1beta stimulation. These new findings show that fibroblasts from different human tissues display different frequencies of cytokine production and this further supports the concept of fibroblast diversity. The sensitivity of this new ELISpot assay is adequate for cytokine detection in just a few cells, unlike the standard ELISA. It should permit ascertaining the frequency of fibroblasts and other adherent cells that produce cytokines and, if desired, can be used in tandem with a standard ELISA to determine total cytokine produced. Moreover, the assay is suitable for normal human adherent cells that are often short-lived and difficult to cultivate. 相似文献
107.
108.
Novak N Haberstok J Kraft S Siekmann L Allam JP Bieber T 《The Journal of allergy and clinical immunology》2001,108(4):588-593
BACKGROUND: The efficacy of traditional Chinese medicine (TCM) as a treatment for atopic dermatitis has been evaluated in clinical trials. Until now, the underlying mechanism of this treatment has remained completely elusive; this is particularly true of its putative effects on dendritic cells (DCs), which might play a pivotal role in the disease. OBJECTIVE: We investigated the influence of a standardized extract from 10 Chinese herbs that was successfully used in clinical trials on the generation of monocyte-derived DCs from atopic donors. METHODS: Detailed phenotypic and functional exploration of DCs generated in the presence of IL-4 and GM-CSF and treated with different concentrations of TCM or a placebo control was performed. RESULTS: TCM profoundly affected the morphology and phenotype of the developing DCs. They lost their typical dendritic morphology and decreased their expression of CD1a as well as the low-affinity IgE receptor CD23. Most importantly, TCM-exposed DCs exhibited a diminished stimulatory activity toward autologous antigen-specific and allogeneic T cells while secreting high amounts of IL-10. CONCLUSION: TCM induces immunopharmacologic alterations on DCs from atopic donors in vitro. These alterations might account, at least in part, for the therapeutic effect of this treatment in AD in vivo. 相似文献
109.
The serious result of hepatitis B (HBV) virus infection is development of hepatocellular carcinoma (HCC). However, the reason of development of HCC in HBV infected patients is still unclear. Recently, the suppression of cell apoptosis is found to relate with the development of cell carcinogenesis, therefore, the expression of apoptosis inhibitor in the virus related cancer line such as hepatoma cell line HepG2.215 was investigated. There are at least six Human apoptosis inhibitors (IAP) have been identified now. They are cIAP1, cIAP2, XIAP, NAPI, survivin and pIAP. Using gene-assay technology, we have recently compared the expression of IAPs in the HepG2.215 cells that persistently expresses Hepatitis B virus by integrated HBV genome with its parent cell line HepG2. The results suggest that there was obviously increase of cIAP2 and cIAP1 in the HepG2.215 cells versus HepG2 cells. Those observations imply a possibility of long time HBV infection could induce the over-expressing apoptosis inhibitors, furthermore, causing the liver cancer. The high expression of cIAP1 and cIAP2 in HBV expressing cells was confirmed by RT-PCR and Northern blot analysis. However, we did not find the change of NIAP and suvivin in HepG2.215 cells. In contrast, the expression of XIAP was down in the HepG2.215 cells comparing with HepG2 cells. How HBV triggers the over-expression of apoptosis inhibitor is unclear. Transient transfection of HepG2 cells with the plasmids expressing different HBV proteins such as S, M, L, X and core proteins did not give a decisive conclusion. Further study is going on now. 相似文献
110.
Tiefenbacher S Davenport MD Novak MA Pouliot AL Meyer JS 《Physiology & behavior》2003,80(2-3):327-331
Self-injurious behavior (SIB) and aggression have been linked to reduced serotonergic (5-HT) functioning in both humans and nonhuman primates. The present study examined serum prolactin and cortisol responses to the 5-HT releasing agent D,L-fenfluramine (FEN) in 24 individually housed rhesus monkeys (Macaca mulatta), 15 of which carried a veterinary record of self-wounding (SW). Subjects received two doses of FEN, 4 and 2 mg/kg, separated by an interval of at least 2 months. For control purposes, monkeys were given an intramuscular saline injection 1 week prior to each FEN challenge. The relationship between the hormonal responses to FEN, wounding history, the rates of self-directed biting and aggression were determined for each animal based on 100 five-minute observations conducted over a period of 12 months surrounding the challenge procedures. Prolactin and cortisol responses to FEN were unrelated either to wounding history or to rates of self-directed biting. However, there were significant inverse correlations between levels of aggression and the prolactin response to both doses of FEN. The present findings provide no evidence for reduced 5-HT system function in rhesus monkeys with SIB under the present challenge conditions. However, the results are consistent with a previously reported inverse relationship between serotonergic activity and aggression. Moreover, a dose-dependent response to FEN was observed only for prolactin, suggesting that this variable is more appropriate than cortisol as an endpoint for FEN challenge in monkeys. 相似文献